Posts Tagged ‘Lungs’

USA and quit smoking: “yes we can!”

16 de fevereiro de 2013 Comentários desligados

A real summary of quit smoking effort at United States can be watch in this graphic that could be named ” Yes we can!”:

20130216-041944 PM.jpg

Video On Planet Earth: Preserve the Pulmonary Atmosphere!

13 de julho de 2012 Comentários desligados

Video On Planet Earth: Preserve the Pulmonary Atmosphere!

@PulmaSA presents a video about your home: planet earth. However this video from NASA where they observe the Earth’s atmosphere at various times, including images of the aurora borealis, serves to remind us of the air we inhale into our lungs, and how we should preserve it. This is also the site of our mission: Inform them so they can protect their real atmosphere, the air in the lung.

After all: @PulmaoSA means: Lungs – Your atmosphere, Your Life!®

Delight and share the video below!

Welcome, and remember: Do not Smoke! Especially around children!

PulmaoSA Pulmonology’s Pearls 1

13 de junho de 2012 Comentários desligados

PulmaoSA Pulmonology’s Pearls 1 Occam’s Razor over Saint’s Triad

The @PulmaoSA is pleased to inaugurate with this post a series named Pulmonology Pearls with discussions whose the goals are:

  • Increasing the Health Professional Culture with a CHPE ( Continuous Health Professional Education);
  • Stimulate multiprofessional discussion about respiratory diseases and
  •  Benefit the patients with respiratory diseases.

Thus Physiotherapists, Nurses, Doctors and medical students and other students from health areas are invited to collaborate. The article will be posted here at PulmaoSA website, but the discussions will happen at  PulmaoSA Group in Facebook.
The discussions could be done in Portuguese and also in English.

So, Be Very Welcome!

The first article may be downloaded from the link below:

Occam’s Razor over Saint’s Triad


@PulmaoSA – Lungs: Your Real Atmosphere: Your Life! ®


PD em pneumologia / Post doc in Pulmonology

10 de junho de 2012 Comentários desligados

20120610-113622 AM.jpg

PD em pneumologia com Bolsa da FAPESP

Agência FAPESP – O Projeto Temático “Avaliação da musculatura ventilatória ins e expiratória nas doenças respiratórias”, apoiado pela FAPESP, oferece uma oportunidade de Bolsa de Pós-Doutorado com duração de 24 meses.

O candidato deve ter: doutoramento concluído há menos de sete anos; experiência com medidas de mecânica ventilatória e fisiologia respiratória; experiência com avaliações das respostas fisiológicas pulmonares ao esforço; experiência de pelo menos um ano em um centro internacional.

O candidato fará parte de um estudo específico da mecânica ventilatória nos pacientes com paralisia diafragmática, envolvendo medidas de pressão transdiafragmática, eletromiografia de superfície e estimulação magnética.

O candidato interessado e que preencha os requisitos em questão deverá enviar currículo atualizado para o professor Carlos Carvalho (, no Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, até o dia 15 de outubro de 2011.

Plano de trabalho da Bolsa de Pós-Doutorado:

A vaga está aberta a brasileiros e estrangeiros. O selecionado receberá Bolsa de Pós-Doutorado da FAPESP (no valor de R$ 5.333,40 mensais), Reserva Técnica e Auxílio-Instalação. A Reserva Técnica de Bolsa de PD equivale a 15% do valor anual da bolsa e tem o objetivo de atender a despesas imprevistas e diretamente relacionadas à atividade de pesquisa.


@PulmaoSA News

Latest News in Copd

7 de junho de 2012 Comentários desligados

20120607-041757 PM.jpg

Latest News in COPD: Olodaterol

(PulmaoSANews) The COPD patients will count with a new possibility to treat this disease that is popular known as crhonic bronchitis or pulmonary emphisema. The US Boehringer announced that the phase ll study with a drug named olodaterol, a long-acting ß 2-agonist (LABA) showed a significant imcrease in lung function of chronic obstructive pulmonary disease (COPD) patients, delivered via the Respimat ® Inhaler.
What does it really means?
It means that COPD patients will count with another option besides Indacaterol (Onbrize ) to decrease their symptoms and make better their quality of life.
Phase ll Study
In this Phase II randomized, double-blind, cross-over study,
olodaterol administered QD as 5 µg or 10 µg provided a significant and identical increase in the lung function parameter FEV 1 over a 24-hour period. This data completes the olodaterol monotherapy Phase II clinical trial program in patients with COPD.




<img src=

From Mother to Mother: Mother’s day tips to quit smoking

14 de maio de 2012 Comentários desligados

From Mother To Mother: Mother’s day tips to quit smoking


The @PulmaoSA has the honour to present an CDC Video  with some tips from former smoker to smokers:


CDC – Center for Diseases Control – USA;

Center of support to smokers from Rio de Janeiro – Brazil

What MDs and Nurse Practioners Need to know About Lung Cancer

15 de abril de 2012 Comentários desligados

What MDs and Nurse Practioners Need to know About Lung Cancer

<div style=”width:425px” id=”__ss_12550194″> <strong style=”display:block;margin:12px 0 4px”><a href=”; title=”Lung Cancer: what MDs and Nurses Need to know” target=”_blank”>Lung Cancer: what MDs and Nurses Need to know</a></strong> <div style=”padding:5px 0 12px”> View more <a href=”; target=”_blank”>PowerPoint</a> from <a href=”; target=”_blank”>Pulmaosa Pulmao</a> </div> </div>

Follow @PulmaoSA no Twitter

%d blogueiros gostam disto: